Barometer Capital Management Inc. Amgen Inc Transaction History

Barometer Capital Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $689,170 - $820,678	-3,185 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $5.33 Million - $5.93 Million	-22,715 Reduced 87.7%	3,185 $810 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $5.12 Million - $6.29 Million	25,900 New	25,900 $6.11 Billion
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $2.84 Million - $3.77 Million	-15,585 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $2.95 Million - $3.79 Million	15,585 New	15,585 $3.76 Million
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $452,175 - $509,700	-2,500 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $10.9 Million - $12.7 Million	-61,200 Reduced 96.08%	2,500 $487,000
Q3 2018 Oct 05, 2018	BUY	$185.29 - $208.89 $11.8 Million - $13.3 Million	63,700 New	63,700 $13.2 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Barometer Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Barometer Capital Management Inc. with notifications on news.